Reduced Expression of Antimicrobial Protein Secretory Leukoprotease Inhibitor and Clusterin in Chronic Rhinosinusitis with Nasal Polyps

J Immunol Res. 2021 Jan 7:2021:1057186. doi: 10.1155/2021/1057186. eCollection 2021.

Abstract

Introduction: Antimicrobial peptides and proteins (AMPs) constitute the first line of defense against pathogenic microorganisms in the airway. The association between AMPs and chronic rhinosinusitis with nasal polyps (CRSwNP) requires further investigations. This study is aimed at investigating the expression and regulation of major dysregulated AMPs in the nasal mucosa of CRSwNP.

Methods: The expression of AMPs was analyzed in nasal tissue from patients with eosinophilic (E) CRSwNP and nonECRSwNP and healthy subjects using RNA sequencing. The 10 most abundant AMPs expressed differentially in CRSwNP patients were verified by real-time PCR, and of these, the expression and regulation of secretory leukoprotease inhibitor (SLPI) and clusterin (CLU) were investigated further.

Results: The 10 most abundant AMPs expressed differentially in CRSwNP compared to healthy control, regardless of subtypes, included BPIFA1, BPIFB1, BPIFB2, CLU, LTF, LYZ, and SLPI, which were downregulated, and S100A8, S100A9, and HIST1H2BC, which were upregulated. ELISA and immunofluorescence confirmed the decreased expression of SLPI and CLU levels in CRSwNP. SLPI is expressed in both nasal epithelial cells and glandular cells, whereas CLU is mainly expressed in glandular cells. AB/PAS staining further demonstrated that both SLPI and CLU were mainly produced by mucous cells in submucosal glands. Furthermore, the numbers of submucosal glands were significantly decreased in nasal polyp tissue of CRSwNP compared to nasal tissue of controls. SLPI was downregulated by TGF-β1 and IL-4 in cultured nasal tissues in vitro, while CLU expression was inhibited by TGF-β1. Glucocorticoid treatment for 2 weeks significantly increased the expression of all downregulated AMPs, but not LYZ. Additionally, budesonide significantly increased the expression of SLPI and CLU in cultured nasal tissues.

Conclusion: The expression of major antimicrobial proteins is significantly decreased in nasal tissue of CRSwNP. The expression of SLPI and CLU is correlated with the numbers of submucosal glands and regulated by inflammatory cytokines and glucocorticoids.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Chronic Disease / drug therapy
  • Clusterin / analysis
  • Clusterin / metabolism*
  • Down-Regulation / immunology
  • Female
  • Gene Expression Profiling
  • Glucocorticoids / administration & dosage
  • Healthy Volunteers
  • Humans
  • Male
  • Middle Aged
  • Nasal Mucosa / immunology
  • Nasal Mucosa / pathology
  • Nasal Polyps / complications
  • Nasal Polyps / drug therapy
  • Nasal Polyps / immunology*
  • Nasal Polyps / pathology
  • Paranasal Sinuses / immunology
  • Paranasal Sinuses / pathology
  • Rhinitis / complications
  • Rhinitis / drug therapy
  • Rhinitis / immunology*
  • Rhinitis / pathology
  • Secretory Leukocyte Peptidase Inhibitor / analysis
  • Secretory Leukocyte Peptidase Inhibitor / metabolism*
  • Sequence Analysis, RNA
  • Sinusitis / complications
  • Sinusitis / drug therapy
  • Sinusitis / immunology*
  • Sinusitis / pathology
  • Up-Regulation / drug effects
  • Up-Regulation / immunology
  • Young Adult

Substances

  • CLU protein, human
  • Clusterin
  • Glucocorticoids
  • SLPI protein, human
  • Secretory Leukocyte Peptidase Inhibitor